Chinese SLE Treatment and Research Group Registry (CSTAR) XIII: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosus.

Yirong XiangMengtao LiHui LuoYanhong WangXinwang DuanCheng ZhaoFeng ZhanZhenbiao WuHongbin LiMin YangJian XuWei WeiLijun WuHanxiao YouJunyan QianXiaoxi YangCan HuangJiuliang ZhaoQian WangXiaomei LengXinping TianYan ZhaoXiaofeng Zeng

Published in: Arthritis research & therapy (2021)

The prevalence of scarring alopecia in SLE patients is 7.80%. Active treatment strategies should be adopted to prevent scarring alopecia occurring.

Keyphrases

systemic lupus erythematosus
end stage renal disease
risk factors
newly diagnosed
chronic kidney disease
ejection fraction
prognostic factors
peritoneal dialysis
rheumatoid arthritis
combination therapy